Guido Guidotti

Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.

Abraham EH, Guidotti G, Rapaport E, Bower D, Brown J, Griffin RJ, Donnelly A, Waitzkin ED, Qamar K, Thompson MA, Ethirajan S, Robinson K.

Purinergic Signal. 2021 May 10. PMID: 33970408

Interactions between the transmembrane domains of CD39: identification of interacting residues by yeast selection.

Paavilainen S, Guidotti G.

ScienceOpen Res. 2014. 2014. PMID: 26258004

Glycans pattern the phase behaviour of lipid membranes.

Subramaniam AB, Guidotti G, Manoharan VN, Stone HA.

Nat Mater. 2013 Feb. 12(2):128-33. PMID: 23178266

Purification of membrane proteins.

Lin SH, Guidotti G.

Methods Enzymol. 2009. 463:619-29. PMID: 19892195

Expression, purification and crystallization of the ecto-enzymatic domain of rat E-NTPDase1 CD39.

Zhong X, Buddha M, Guidotti G, Kriz R, Somers W, Mosyak L.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Nov 01. 64(Pt 11):1063-5. PMID: 18997343

Bilayer mechanical properties regulate the transmembrane helix mobility and enzymatic state of CD39.

Grinthal A, Guidotti G.

Biochemistry. 2007 Jan 09. 46(1):279-90. PMID: 17198399

CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?

Grinthal A, Guidotti G.

Purinergic Signal. 2006 Jun. 2(2):391-8. PMID: 18404478

A eukaryotic carboxyl-terminal signal sequence translocating large hydrophilic domains across membranes.

Zhong X, Malhotra R, Guidotti G.

FEBS Lett. 2005 Oct 24. 579(25):5643-50. PMID: 16214140

Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage.

Fumarola C, La Monica S, Guidotti GG.

J Cell Physiol. 2005 Jul. 204(1):155-65. PMID: 15605414

Distinctive roles of endoplasmic reticulum and golgi glycosylation in functional surface expression of mammalian E-NTPDase1, CD39.

Zhong X, Kriz R, Kumar R, Guidotti G.

Biochim Biophys Acta. 2005 May 25. 1723(1-3):143-50. PMID: 15777625